Octodrine
 | |
| Systematic (IUPAC) name | |
|---|---|
| 6-methylheptan-2-amine | |
| Clinical data | |
| Identifiers | |
543-82-8  | |
| None | |
| PubChem | CID 10982 |
| ChemSpider | 10517 |
| UNII |
3GQ9E911BI  |
| Synonyms | Ottodrina, Vaporpac, Amidrine, 2-Amino-6-methylheptane, 1,5-Dimethylhexylamine, 6-Methyl-2-heptylamine, 2-Heptanamine, & 6-methyl.[1] |
| Chemical data | |
| Formula | C8H19N |
| 129.24 g/mol | |
|
SMILES
| |
| |
| (what is this?) (verify) | |
Octodrine is a stimulant drug whose pharmacology was briefly studied in the early 1950s.[2] A platinum complex form of the molecule was also investigated as a possible anti-tumor drug.[3]
References
- ↑ Octodrine. PubChem. . URL:https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=10982. Accessed: 11-26-2012. (Backed-up via FileRose at http://filerose.com/ziicsw14idbs/Octodrine_-_PubChem.pdf)
- ↑ Semenza, F. Contribution to the pharmacological study of 2-methyl-6-aminoheptane. Bollettino della Società italiana di biologia sperimentale. 1951;27(3 bis):354–7. PMID 14858666.
- ↑ Craciunescu DG. Structure-antitumour activity relationships for new platinum complexes. Chem Biol Interact. 1982;42(2):153–64. doi:10.1016/0009-2797(82)90129-6. PMID 6891293.